Technetium99mRedBloodCellChecker

Tc-99m RBC

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity Tc-99m
Open selection

Utility description: Tc-99m RBC

Tc-99m RBC Quality Checker — Technetium-99m Labeled Red Blood Cells for Heart and GI Tract

ℹ️  Utility checks critical parameters of Tc-99m RBC:
    • Labeling efficiency (≥95%)
    • Free pertechnetate (≤3%)
    • Colloidal technetium (≤2%)
    • pH (4.5–7.5), endotoxins, sterility

⚠️  CRITICAL: Low labeling (<95%) leads to stomach accumulation.
    This mimics gastrointestinal bleeding or interferes with cardiac assessment.

Usage:
  Technetium99mRedBloodCellChecker.exe                            → demo mode (console output)
  Technetium99mRedBloodCellChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,TotalActivityMBq,LabelingEfficiencyPercent,FreePertechnetatePercent,ReducedHydrolyzedTcPercent,pH,EndotoxinsEU,SterilityTest,HematocritPercent,LabelingMethod

Example (sterility: 0=sterile, 1=contaminated):
  TC99M-RBC-2026-100,925.0,98.0,1.5,0.5,7.4,10.0,0,45.0,InVivo

Supported methods:
• InVivo — injection of stannous pyrophosphate, then pertechnetate
• InVitro — labeling in a test tube (maximum efficiency)
• ModifiedInVivo — blood draw, in vitro labeling, return to patient

— WHY IS THIS NEEDED?
Tc-99m Labeled Red Blood Cells (RBC) is a blood-pool agent:
• Cardiology: Gold standard for assessing left ventricular function (MUGA/RNV). Allows precise calculation of ejection fraction.
• Gastroenterology: Detection of gastrointestinal bleeding sources (even very slow ones).
• Oncology/Hematology: Imaging of liver hemangiomas, spleen.

⚠️  CRITICAL:
• Labeling Efficiency ≥95% — The most important characteristic. If technetium is not bound to the RBC, it behaves like free pertechnetate or colloid.
• Free pertechnetate ≤3% — Enters stomach and thyroid. When searching for GI bleeding, stomach uptake can be mistaken for bleeding or obscure it. In cardiology, stomach background interferes with inferior wall assessment.
• Reduced/Hydrolyzed Tc ≤2% — Accumulates in liver and spleen. Interferes with hemangioma visualization and creates background for the heart.
• Labeling Method:
  - In Vivo: Simpler, but lower efficiency (depends on patient's hematocrit, medications).
  - In Vitro: Highest efficiency (>98%), but technically complex (contamination risk).
  - Modified In Vivo: Compromise option.
• pH 4.5–7.5 — Important for RBC integrity. Too acidic or alkaline environment causes hemolysis.
• Endotoxins ≤175 EU/vial, Sterility — standard requirements for IV injections.

Key features:
• Strict control of labeling efficiency
• Assessment of free technetium impact on specific studies (GI/Heart)
• Support for different labeling methods

Critical parameters:
• Labeling efficiency: ≥95.0%
• Free pertechnetate: ≤3.0%
• Colloidal Tc: ≤2.0%
• pH: 4.5–7.5
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth

💡 Usage tips:
1. To determine labeling efficiency, centrifugation of the patient's blood sample after drug administration is used.
2. For In Vivo method, ensure 20-30 minutes have passed between tin (Sn) and technetium (Tc) injections.
3. Some medications (heparin, certain antibiotics, chemotherapy) interfere with In Vivo labeling. In such cases, use In Vitro method.
4. Patient hematocrit affects tin distribution; dosage may require correction in anemia.

⚠️ Note: The quality of RBC study depends 100% on labeling quality. Poorly labeled RBCs make the study diagnostically worthless, especially in bleeding searches where high specificity of the signal within the vascular bed is required.

input.csv

BatchNumber,TotalActivityMBq,LabelingEfficiencyPercent,FreePertechnetatePercent,ReducedHydrolyzedTcPercent,pH,EndotoxinsEU,SterilityTest,HematocritPercent,LabelingMethod
TC99M-RBC-2026-100,925.0,98.0,1.5,0.5,7.4,10.0,0,45.0,InVivo
TC99M-RBC-FAIL-101,900.0,85.0,12.0,3.0,7.2,15.0,0,42.0,InVivo
TC99M-RBC-VITRO-102,740.0,99.5,0.5,0.0,7.5,5.0,0,40.0,InVitro

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Technetium99mRedBloodCellChecker for Tc-99m RBC.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of Tc-99m RBC:
  • • Labeling efficiency (≥95%)
  • • Free pertechnetate (≤3%)
  • • Colloidal technetium (≤2%)
  • • pH (4.5–7.5), endotoxins, sterility
  • ⚠️ CRITICAL: Low labeling (<95%) leads to stomach accumulation.
  • BatchNumber,TotalActivityMBq,LabelingEfficiencyPercent,FreePertechnetatePercent,ReducedHydrolyzedTcPercent,pH,EndotoxinsEU,SterilityTest,HematocritPercent,LabelingMethod
  • Example (sterility: 0=sterile, 1=contaminated):
  • ⚠️ CRITICAL:
  • • Labeling Efficiency ≥95% — The most important characteristic. If technetium is not bound to the RBC, it behaves like free pertechnetate or colloid.
  • • Free pertechnetate ≤3% — Enters stomach and thyroid. When searching for GI bleeding, stomach uptake can be mistaken for bleeding or obscure it. In cardiology, stomach background interferes with inferior wall assessment.
  • • Reduced/Hydrolyzed Tc ≤2% — Accumulates in liver and spleen. Interferes with hemangioma visualization and creates background for the heart.
  • • Endotoxins ≤175 EU/vial, Sterility — standard requirements for IV injections.
  • • Assessment of free technetium impact on specific studies (GI/Heart)

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Tc-99m RBC using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringTC99M-RBC-2026-100Batch or lot identifier used for traceability.
2TotalActivityMBqdecimal925.0Radioactivity value used for release, decay or dose-related assessment.
3LabelingEfficiencyPercentdecimal98.0Controlled input parameter used by the deterministic QC rules.
4FreePertechnetatePercentdecimal1.5Free radionuclide / unbound species; important for non-target uptake and toxicity.
5ReducedHydrolyzedTcPercentdecimal0.5Controlled input parameter used by the deterministic QC rules.
6pHdecimal7.4Solution pH; relevant for stability, compatibility and administration.
7EndotoxinsEUdecimal10.0Bacterial endotoxins; critical for parenteral administration.
8SterilityTestflag / boolean0Sterility result; critical release parameter.
9HematocritPercentdecimal45.0Controlled input parameter used by the deterministic QC rules.
10LabelingMethodstring / decimalInVivoControlled input parameter used by the deterministic QC rules.
BatchNumber,TotalActivityMBq,LabelingEfficiencyPercent,FreePertechnetatePercent,ReducedHydrolyzedTcPercent,pH,EndotoxinsEU,SterilityTest,HematocritPercent,LabelingMethod
TC99M-RBC-2026-100,925.0,98.0,1.5,0.5,7.4,10.0,0,45.0,InVivo
TC99M-RBC-FAIL-101,900.0,85.0,12.0,3.0,7.2,15.0,0,42.0,InVivo
TC99M-RBC-VITRO-102,740.0,99.5,0.5,0.0,7.5,5.0,0,40.0,InVitro

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Tc-99m RBC, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "technetium99m-red-blood-cell-checker",
  "api": "Tc-99m RBC",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "TC99M-RBC-2026-100",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "TotalActivityMBq",
      "value": "925.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "LabelingEfficiencyPercent",
      "value": "98.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreePertechnetatePercent",
      "value": "1.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "ReducedHydrolyzedTcPercent",
      "value": "0.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "7.4",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "EndotoxinsEU",
      "value": "10.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SterilityTest",
      "value": "0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

Cardiology QC Suite

QC package for cardiology medicines: antihypertensives, anticoagulants, antiplatelets, lipid-lowering and antiarrhythmic medicines plus supporting QC checks.

Open

Endocrinology QC Suite

QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.

Open

Gastroenterology QC Suite

QC package for gastroenterology: PPIs, antiemetics, prokinetics, IBD medicines, laxatives, enzymes and GI anti-infectives.

Open

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: Tc-99m

Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.

Open

RPH organ/system: blood, cells and marrow

WBC/RBC/platelet labelling, blood volume, survival, blood-pool and cellular release workflows.

Open

RPH organ/system: bone and musculoskeletal

Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.

Open

RPH organ/system: cardiovascular

Myocardial perfusion, cardiac PET/SPECT, ventricular function, blood-pool and perfusion tracers.

Open

RPH organ/system: endocrine, thyroid and NET

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Open

RPH organ/system: hepatobiliary and GI

HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH use case: labelled cells and blood-pool workflows

Leukocytes, red blood cells, platelets and autologous cell workflows: labeling efficiency, viability, free activity, recovery and release before reinjection.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open